FDA Coronavirus (COVID-19) Update: August 11th, 2020

Silver Spring, MD – The U.S. Food and Drug Administration has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:

As part of the FDA’s effort to protect consumers, the agency issued a warning letter to one firm for selling unapproved products with fraudulent COVID-19 Coronavirus claims.

[Read more]

Developing a COVID-19 Vaccine Quickly Proving to be a Daunting Task But Progress Still Expected

Palm Beach, FL – Rapid development of a vaccine to prevent the global health crisis is a global imperative, and defining the stakes and potential hurdles is critical because regulatory and medical decisions are based on benefit/risk calculations.

The benefit of developing an effective vaccine is very high, and even greater if it can be deployed in time to prevent repeated or continuous epidemics.

[Read more]